about
Cross-cultural development of an EORTC questionnaire to assess health-related quality of life in patients with testicular cancer: the EORTC QLQ-TC26Diagnostic advances and new trends for the treatment of primary central nervous system lymphoma.Carboplatin and teniposide as third-line chemotherapy in patients with recurrent oligodendroglioma or oligoastrocytoma: a phase II study.First-line chemotherapy with cisplatin plus fractionated temozolomide in recurrent glioblastoma multiforme: a phase II study of the Gruppo Italiano Cooperativo di Neuro-Oncologia.Lymphopenia and clinical outcome of elderly patients treated with sunitinib for metastatic renal cell cancer.Safety and efficacy of sunitinib in patients from Italy with metastatic renal cell carcinoma: final results from an expanded-access trial.Adjuvant Carboplatin Treatment in 115 Patients With Stage I Seminoma: Retrospective Multicenter Survey.Histotype-tailored neoadjuvant chemotherapy versus standard chemotherapy in patients with high-risk soft-tissue sarcomas (ISG-STS 1001): an international, open-label, randomised, controlled, phase 3, multicentre trial.High-dose chemotherapy with bone marrow rescue for high-grade gliomas in adults.New strategy developments in brain tumor therapy.Glycosaminoglycan Profiling in Patients' Plasma and Urine Predicts the Occurrence of Metastatic Clear Cell Renal Cell Carcinoma.Changing boundaries in the treatment of malignant gliomas.Non-cytotoxic therapies for malignant gliomas.Is intra-arterial chemotherapy useful in high-grade gliomas?Controversies in the therapy of low-grade glioma: when and how to treat.Retaining the long-survive capacity of Circulating Tumor Cells (CTCs) followed by xeno-transplantation: not only from metastatic cancer of the breast but also of prostate cancer patients.Medulloblastomas: do molecular and biologic markers indicate different prognoses and treatments?Recommendations for the management of malignant gliomas in the elderly.Treatment options for early breast cancer in elderly women.Management of muscle-invasive bladder cancer in the elderly.Multidimensional geriatric evaluation in elderly cancer patients: a practical approach.New standards in the chemotherapy of metastatic hormone-refractory prostate cancer.Epicure: a European epidemiological study of patients with an advanced or metastatic Urothelial Carcinoma (UC) having progressed to a platinum-based chemotherapyDynamic changes of live/apoptotic circulating tumour cells as predictive marker of response to sunitinib in metastatic renal cancer.Long-term response to first-line trabectedin in an elderly female patient with a metastatic leiomyosarcoma unfit for anthracycline.Adjuvant chemotherapy for soft tissue sarcomas: a 10-year mono-institutional experience.Development of an oncological-multidimensional prognostic index (Onco-MPI) for mortality prediction in older cancer patients.Primary rectal carcinoma in patients with stage IV resectable disease at diagnosis.Genotype-driven phase I study of irinotecan administered in combination with fluorouracil/leucovorin in patients with metastatic colorectal cancer.Ifosfamide-related encephalopathy in elderly patients : report of five cases and review of the literature.Chemotherapy and targeted agents for elderly women with advanced breast cancer.Analysis of all subunits, SDHA, SDHB, SDHC, SDHD, of the succinate dehydrogenase complex in KIT/PDGFRA wild-type GIST.Gastrointestinal stromal tumors: report of an audit and review of the literature.Prognostic Value of Plasma and Urine Glycosaminoglycan Scores in Clear Cell Renal Cell Carcinoma.Management of primary and advanced breast cancer in older unfit patients (medical treatment).Neoadjuvant sirolimus for a large hepatic perivascular epithelioid cell tumor (PEComa).Systemic immune-inflammation index predicts the clinical outcome in patients with metastatic renal cell cancer treated with sunitinib.Adjuvant and neoadjuvant chemotherapy for soft tissue sarcomas.Targeted approaches to triple-negative breast cancer: current practice and future directions.Screening tools for multidimensional health problems warranting a geriatric assessment in older cancer patients: an update on SIOG recommendations†.
P50
Q28261683-DEE4951F-CF04-403A-9184-3E3B4029DF82Q30700872-6E4D0DB9-37D1-4253-8B4D-4F277FC62D42Q33357716-86F5F460-6815-4767-9C56-C80B978E46AEQ33360637-854B52C1-1B68-4A41-BFDD-77D2F0B00F10Q33413133-E03CE68E-7826-42D1-9240-279ADB5D0509Q33419797-70756EBF-029E-4583-A5EE-186BB4041868Q33429261-27094259-9E6E-42B7-9335-50416FADF04DQ33441802-C998B5B5-A562-4561-897D-19FEF8157D58Q34211011-27E0B434-6E10-4E24-91E4-3CE7249F08F4Q34373060-2E59E326-BFDB-4DD2-B764-362D41A8A7DAQ34526816-A42C23B8-7A52-42BE-A7AE-5F3DE8D7B2BAQ34734197-90D8B58D-C753-492D-B885-10469D0036C4Q34771514-7D3076F3-A1FF-4AE2-BB0E-8228E328388CQ34969194-F67226DA-CD1F-4408-AAD4-9F8969F10421Q34969223-CC79A84A-6746-416A-95AC-9F60BF1F0E43Q34971918-A916715B-1955-4D75-A303-37277D869C7CQ35576163-453F02A7-CF66-4339-BC6C-99D7CEF0DB16Q35576169-7C0760C2-AA78-4465-90BC-60FBF87515DEQ35728668-880E0B0D-6370-4018-BF0B-013AE369E164Q35987747-742B6845-A4E1-4F32-9920-D59EB676D103Q35987994-8F30168D-C440-481F-ACE3-5FFEB1B3BB18Q36066144-1AAB4EFB-3AC8-4BFC-8A74-C0F1A95DE533Q36143699-FA88608F-8F35-4B2B-BF17-28C0F7C9DC70Q36387861-067EC1EC-DE98-4A62-992E-4CFD5D487C9AQ36530034-CA2D7EF4-0D79-4505-AAC2-FB2BA104C3DEQ36573310-DA0B98DD-E77A-41D7-AF46-C92241E7B3D4Q36789292-84F919DC-56AB-4751-9AA6-86C2C91CD2B9Q36804242-477A53B1-C34B-438F-907A-CF16FE46C038Q36915163-01C6477F-16B9-4C64-A195-11ADD8FD31A0Q36978163-262CFC26-A05B-44A3-90EC-61CA109EA0EFQ37320613-5083F21D-EEC9-421A-AFAE-33BBD006EC57Q37397647-476AA0A8-925F-4BB7-BC64-5313782FC45CQ37428518-4EB7F6D4-B969-4659-BF0E-3FFA7AA09FD6Q37433431-780C8C8A-E4C2-4163-AAEC-E29B5EAF698EQ37599110-566062AB-33CB-4377-9010-76D3F62B6640Q37619835-2C4DFDF3-10C9-463D-B8C9-5E9E2651893EQ37688103-FDCF5C51-DE34-4320-B6B8-FB1D20FB9AA8Q38070724-6EF80FAE-DF66-489E-A888-61FFDFE9E226Q38070725-CBCB1686-EBA1-441D-9CE3-EE24094ACC7BQ38220842-C780E976-1FC7-4865-8D59-1F31F491A3A3
P50
description
onderzoeker
@nl
researcher
@en
հետազոտող
@hy
name
U Basso
@nl
Umberto Basso
@en
Umberto Basso
@es
type
label
U Basso
@nl
Umberto Basso
@en
Umberto Basso
@es
altLabel
U Basso
@en
prefLabel
U Basso
@nl
Umberto Basso
@en
Umberto Basso
@es
P106
P1153
6603953568
P21
P31
P496
0000-0002-5075-2177